A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study Of Novel Erythropoiesis Stimulating Protein (NESP) In Patients Undergoing Platinum Treatment For Lung Cancer

Heather Jones, MD

University of Pennsylvania Cancer
Ultima Vez Modificado: 13 de mayo del 2001

Translation for this article does not exist